Market Overview

Benzinga's Top Downgrades

Share:
Related PRXL
Avondale Downgrades PAREXEL To Underperform, Cites MSA-Laden Backlog Concerns
Benzinga's Top Upgrades
Related MT
Mid-Morning Market Update: Markets Mostly Flat; Coca-Cola Earnings Top Expectations
Credit Suisse's Market-Moving Call: ArcelorMittal In Midst Of First Upcycle In 5 Years
Vale seeing improved iron ore demand in China (Seeking Alpha)

Analysts at Jefferies downgraded PAREXEL International (NASDAQ: PRXL) from “buy” to “hold.” PAREXEL's shares closed at $32.38 yesterday. PAREXEL's trailing-twelve-month ROA is 4.01%.

Analysts at Citigroup downgraded ArcelorMittal (NYSE: MT) from “buy” to “neutral.” ArcelorMittal's shares closed at $14.65 yesterday. ArcelorMittal's trailing-twelve-month profit margin is 0.69%.

Analysts at Goldman Sachs downgraded MeadWestvaco (NYSE: MWV) from “buy” to “neutral.” MeadWestvaco's shares closed at $31.20 yesterday. MeadWestvaco's PEG ratio is 2.16.

RBC Capital downgraded Endo Health Solutions (NASDAQ: ENDP) from “outperform” to “sector perform.” Endo Health's shares closed at $31.51 yesterday. Endo Health's trailing-twelve-month ROA is 5.13%.

Latest Ratings for PRXL

DateFirmActionFromTo
Apr 2016Avondale PartnersMaintainsUnderperform
Mar 2016SunTrust Robinson HumphreyUpgradesNeutralBuy
Jan 2016Avondale PartnersDowngradesMarket PerformMarket Underperform

View More Analyst Ratings for PRXL
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ENDP + MT)

View Comments and Join the Discussion!